Diagnostic Outcomes of Clinically Diagnosed Lichen Planus-Like Keratosis
Main Article Content
Keywords
general dermatology, medical dermatology, lichen planus like keratosis (LPLK), benign lichenoid keratosis (BLK), basal cell carcinoma (BCC), non-melanoma skin cancer (NMSC), Squamous cell carcinoma in situ (SCCIS)
Abstract
Lichen planus-like keratosis (LPLK), also known as benign lichenoid keratosis (BLK), are pink/red-brown papules that are thought to represent regressing inflamed solar lentigo or seborrheic keratosis. Prior studies have evaluated the differential diagnosis before biopsy for histologically diagnosed LPLK/BLK; however, diagnostic outcomes and prevalence of malignancy in clinically appearing LPLK/BLK have not been reported. Here, we report a single-institution, retrospective chart review from 2013-2020 evaluating the prevalence of malignancy in a set of lesions clinically appearing as LPLK/BLK. The most common first differential diagnoses were BCC (42%) and LPLK/BLK (35%). The most common histologic diagnosis was BCC (28%), followed by LPLK/BLK (26%). Considering all lesions, 44% were diagnosed as malignant (28% BCC, 14% SCCIS, 1.4% melanoma) and 26% were diagnosed as LPLK/BLK. Conversely, considering lesions with LPLK/BLK first in the differential diagnosis, 33% had a malignant diagnosis (19% BCC, 13% SCCIS, 1% melanoma) and 36% had a diagnosis of LPLK/BLK. These results provide valuable insight into characterizing diagnostic outcomes and malignancy prevalence for clinically appearing LPLK/BLK to guide patient-centered shared decision-making.
References
2. Watanabe S, Sawada M, Dekio I, Ishizaki S, Fujibayashi M, Tanaka M. Chronology of lichen planus-like keratosis features by dermoscopy: a summary of 17 cases. Dermatol Pract Concept. 2016;6(2). doi:10.5826/DPC.0602A06
3. Morgan MB, Stevens GL, Switlyk S. Benign lichenoid keratosis: a clinical and pathologic reappraisal of 1040 cases. Am J Dermatopathol. 2005;27(5):387-392. doi:10.1097/01.DAD.0000175533.65486.84
4. Vincek V. Lichen planus-like keratosis: clinicopathological evaluation of 1366 cases. Int J Dermatol. 2019;58(7):830-833. doi:10.1111/IJD.14358
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.